Patients with pre-existing heart conditions, hypertension, or family history of cardiac disease should discuss semaglutide use with their primary care physician before starting treatment to establish a baseline and monitoring plan
Doctors often order the ANA test when patients present with symptoms that may indicate an autoimmune disorder
The coprimary end points for SURMOUNT1 and SURMOUNT2 are mean percentage change in body weight and the percentage of study participants achieving 5% body weight reduction from randomization to 72 weeks
Medication side effects
Yes, tirzepatide significantly reduces appetite by acting on brain areas that control hunger and slowing gastric emptying, leading to reduced food cravings, diminished interest in eating, and feeling satisfied with smaller portions
Your surgical team needs clear communication about your medication schedule, and PlexusDx works with your healthcare providers to ensure proper timing for stopping and restarting your injections around your procedure date
